Skip to main content

Efavirenz

NDC 65862-105 · Aurobindo Pharma Limited

Generic nameEfavirenz
Dosage formCAPSULE
RouteORAL
Active ingredient(s)EFAVIRENZ
Strength100 mg/1
Pharmacologic classCytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
Marketing categoryANDA

Packages

65862-105-10 — 3 BLISTER PACK in 1 CARTON (65862-105-10) / 10 CAPSULE in 1 BLISTER PACK

65862-105-30 — 30 CAPSULE in 1 BOTTLE (65862-105-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0093-5234 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 31722-504 — Efavirenz, 31722-736 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 33342-013 — Efavirenz, 33342-138 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-915 — Efavirenz, emtricitabine and tenofovir disoproxil fumarate, 42385-928 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-929 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 49502-475 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 65862-049 — Efavirenz, 65862-104 — Efavirenz, 65862-106 — Efavirenz, 65862-497 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 69097-210 — efavirenz, emtricitabine and tenofovir disoproxil fumarate, 69097-301 — Efavirenz, 72162-2565 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 72865-172 — EFAVIRENZ

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels